(HealthDay News) — More community hospitals are giving tissue plasminogen activator (tPA) medication to stroke victims, improving their chances of survival and recovery, new research indicates. The ...

Previously, the guidelines said the drug must be delivered within three hours of the onset of symptoms. The drug, called tissue plasminogen activator, or tPA, breaks down blood clots in the brain, and ...

November 18, 2010 — About half of stroke patients cannot communicate their body weight (BW), only 1 in 5 relatives are able to provide this information, and a physician's or nurse's visual estimation ...

(HealthDay News) — Endovascular therapy with mechanical thrombectomy in ischemic stroke is superior to standard treatment with tissue plasminogen activator (tPA) for preserving brain function, ...

Adult patients with sickle cell disease (SCD) who experience a stroke caused by a clot (i.e., ischemic strokes or IS) can be treated safely with tissue plasminogen activator (tPA) if they qualify, ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Treatment of stroke with tissue plasminogen activator within 4.5 hours of stroke onset reduces ...

Confirmation that earlier treatment with thrombolysis in patients with acute ischemic stroke translates into better outcomes has come from a registry study involving almost 60,000 patients. In the ...

Ischemic stroke, caused by a clot in a blood vessel that cuts off blood flow to the brain, is the most common form of stroke and the second leading cause of death for those over 60. In the United ...

Research presented today at the International Stroke Conference (ISC) in Nashville, Tenn. and published online in The New England Journal of Medicine (NEJM) found that the addition of the Solitaire™ ...